EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are two major types of omega-3 fatty acids that play important roles in brain and eye health as well as cardiovascular health. They are commonly found in fish and omega-3 supplements. EPA and DHA support overall well-being and help reduce risk of chronic diseases. They are used in infant formula, pharmaceuticals, functional foods and animal feed.

The global EPA and DHA market is estimated to be valued at US$ 2135.1 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
The increasing health consciousness among consumers is a key driver fueling the growth of EPA and DHA market. People are increasingly realizing the diverse health benefits of omega-3 fatty acids in reducing risks of heart disease, boosting brain function, and alleviating inflammation. As consumers are more willing to adopt preventive healthcare approaches, the demand for EPA and DHA supplements and enriched food products has surged substantially. Furthermore, rising cases of lifestyle diseases and disorders like arthritis, depression etc have also raised the importance of dietary intervention using functional ingredients like EPA and DHA. In order to cater to burgeoning demand, manufacturers are significantly investing in new product development and capacity expansions.

SWOT Analysis

Strength: EPA and DHA are omega-3 fatty acids that are extremely beneficial for heart and brain health. The growing awareness about the health benefits of consuming EPA and DHA is driving the growth of this market. The surging instances of lifestyle diseases like heart problems, diabetes is further fuelling the demand.

Weakness: High production cost associated with EPA and DHA extraction makes them expensive. This hinders mass consumption of products containing EPA and DHA. Fluctuating fish stocks also disrupts the stable supply of EPA and DHA.

Opportunity: Increasing health-conscious consumer base globally presents lucrative scope. The growing vegan population demanding for plant-based EPA and DHA supplements also offers opportunities. Rising elderly populace susceptible to age-related illnesses boosts demand.

Threats: Stringent regulations pertaining to product quality standards can squeeze margins. Intense competition and pricing pressures from substitutes is a challenge. Fluctuating raw material prices owing to changing climate is also a threat.

Key Takeaways

Global EPA And DHA Market Size is expected to witness high growth. From 2024 to 2031 the market is projected to rise at a CAGR of 4.5% annually to reach a value of US$ 3145.3 Mn by 2031 from US$ 2135.1 Mn in 2024.

Regional analysis: Asia Pacific dominates currently due to large consumer base and growing health consciousness. China, India and Japan are major markets driving regional growth. North America follows Asia Pacific owing to increasing omega-3 fortified food products. Europe is also a substantial market led by UK, Germany and Nordic nations.

Key players analysis: Key players operating in the EPA and DHA market are KHS GmbH, Tetra Pak International SA (Tetra Laval Group), Syntegon Technology GmbH, JBT Corporation, GEA Group Aktiengesellschaft, Sidel Group (Tetra Laval Group), Krones AG, Ronchi Mario SPA, Coesia Group, and Barry-Wehmiller Companies Inc. The landscape is fragmented with these majors competing based on technological innovation, product quality and expansion strategies.

Explore More Related Article On This Topic: https://www.newsanalyticspro.com/the-global-epa-and-dha-market-is-estimated-to-propelled-by-rising/

Explore More Related Article : http://insightprobe.weebly.com/blog/crafting-success-navigating-the-evolving-landscape-of-the-india-alcohol-market